{"id":"https://openalex.org/W7108631991","doi":"https://doi.org/10.1182/blood-2025-4482","title":"Real-world treatment patterns and clinical outcomes in high-risk Mantle Cell Lymphoma: A retrospective analysis","display_name":"Real-world treatment patterns and clinical outcomes in high-risk Mantle Cell Lymphoma: A retrospective analysis","publication_year":2025,"publication_date":"2025-11-03","ids":{"openalex":"https://openalex.org/W7108631991","doi":"https://doi.org/10.1182/blood-2025-4482"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2025-4482","doi":"https://doi.org/10.1182/blood-2025-4482","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-4482","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/4482/2458514/blood-7229-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/4482/2458514/blood-7229-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Preetesh Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Preetesh Jain","raw_affiliation_strings":["1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Teschemaker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Teschemaker","raw_affiliation_strings":["2AstraZeneca, Gaithersburg, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Gaithersburg, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Essam Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Essam Ibrahim","raw_affiliation_strings":["2AstraZeneca, Gaithersburg, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Gaithersburg, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Taavy Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153546","display_name":"Flatiron Health (United States)","ror":"https://ror.org/0508h6p74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153546"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taavy Miller","raw_affiliation_strings":["3Flatiron Health, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Flatiron Health, New York, United States","institution_ids":["https://openalex.org/I4210153546"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Danni Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153546","display_name":"Flatiron Health (United States)","ror":"https://ror.org/0508h6p74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153546"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danni Zhao","raw_affiliation_strings":["3Flatiron Health, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Flatiron Health, New York, United States","institution_ids":["https://openalex.org/I4210153546"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ayush Kris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153546","display_name":"Flatiron Health (United States)","ror":"https://ror.org/0508h6p74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153546"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayush Kris","raw_affiliation_strings":["3Flatiron Health, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Flatiron Health, New York, United States","institution_ids":["https://openalex.org/I4210153546"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ahmed Sawas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153546","display_name":"Flatiron Health (United States)","ror":"https://ror.org/0508h6p74","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153546"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Sawas","raw_affiliation_strings":["3Flatiron Health, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Flatiron Health, New York, United States","institution_ids":["https://openalex.org/I4210153546"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Debbie Adkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debbie Adkins","raw_affiliation_strings":["4AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anouchka Chelles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anouchka Chelles","raw_affiliation_strings":["2AstraZeneca, Gaithersburg, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Gaithersburg, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Victoria Otero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria Otero","raw_affiliation_strings":["2AstraZeneca, Gaithersburg, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca, Gaithersburg, United States","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":null,"display_name":"Tycel Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tycel Phillips","raw_affiliation_strings":["5City of Hope Comprehensive Cancer Center, Duarte, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5City of Hope Comprehensive Cancer Center, Duarte, United States","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"146","issue":"Supplement 1","first_page":"4482","last_page":"4482"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.8579999804496765},{"id":"https://openalex.org/keywords/ki-67-proliferation-index","display_name":"Ki-67 proliferation index","score":0.8970000147819519},{"id":"https://openalex.org/keywords/blastoid-morphology","display_name":"blastoid morphology","score":0.906000018119812},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6579999923706055},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9399999976158142},{"id":"https://openalex.org/keywords/time-to-treatment-discontinuation","display_name":"time to treatment discontinuation","score":0.8610000014305115},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.5759999752044678},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.3840000033378601}],"concepts":[{"id":"https://openalex.org/C2775912362","wikidata":"https://www.wikidata.org/wiki/Q1566901","display_name":"Blastoid","level":4,"score":0.8335999846458435},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8123000264167786},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6963000297546387},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6539000272750854},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6043999791145325},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5885999798774719},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5389999747276306},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5123000144958496},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.41999998688697815},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41839998960494995},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4133000075817108},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.37599998712539673},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.31380000710487366},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.30469998717308044},{"id":"https://openalex.org/C2778476033","wikidata":"https://www.wikidata.org/wiki/Q1667625","display_name":"International Prognostic Index","level":4,"score":0.3046000003814697},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2863999903202057},{"id":"https://openalex.org/C200544954","wikidata":"https://www.wikidata.org/wiki/Q516389","display_name":"Penetrance","level":4,"score":0.274399995803833},{"id":"https://openalex.org/C2910938049","wikidata":"https://www.wikidata.org/wiki/Q7249605","display_name":"Proliferation index","level":3,"score":0.26919999718666077},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2563999891281128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2025-4482","doi":"https://doi.org/10.1182/blood-2025-4482","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-4482","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/4482/2458514/blood-7229-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2025-4482","doi":"https://doi.org/10.1182/blood-2025-4482","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2025-4482","pdf_url":"https://ashpublications.org/blood/article-pdf/146/Supplement 1/4482/2458514/blood-7229-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7108631991.pdf","grobid_xml":"https://content.openalex.org/works/W7108631991.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Mantle":[2],"cell":[3],"lymphoma":[4],"(MCL)":[5],"is":[6,24,676],"a":[7,47,91,205,238,244,617],"biologically":[8],"and":[9,37,42,50,68,82,162,175,213,254,274,295,307,351,370,405,428,434,458,471,486,499,524,542,564,586,605,640,670],"clinically":[10],"heterogeneous":[11],"disease":[12,138,301],"with":[13,86,115,269,281,298,463,491],"variable":[14],"prognosis.":[15],"While":[16],"the":[17,77,101,132,142,230,266,278,289,305,311,320,335,348,355,360,366,386,403,425,431,439,449,477,509,521,527,539,549,561,571,583,593,610,630,649,656],"MCL":[18,36,64,88,93,116,612,619,651],"International":[19],"Prognostic":[20],"Index":[21],"(MIPI)":[22],"score":[23,315],"commonly":[25,511],"used":[26,100,382,512],"for":[27,204,211,229,347,354,603,658],"prognosis,":[28],"it":[29],"alone":[30],"does":[31],"not":[32],"adequately":[33],"represent":[34],"high-risk":[35,40,63,87,231,267,290,306,321,349,367,387,404,426,440,450,522,540,562,584,618,635,672],"excludes":[38],"critical":[39],"biologic":[41],"genetic":[43],"features,":[44],"such":[45],"as":[46],"TP53":[48,145,206,239,604],"mutation":[49],"blastoid/pleomorphic":[51],"morphology,":[52,150,253],"which":[53],"are":[54],"known":[55],"to":[56,75,90,112,171,178,646,667,678,683],"predict":[57],"inferior":[58],"outcomes.":[59,686],"In":[60,448,476,504,597],"real-world":[61,165,169,176,599],"practice,":[62],"remains":[65],"poorly":[66],"characterized":[67],"inconsistently":[69],"defined.":[70],"Therefore,":[71],"this":[72,598],"study":[73,99,615],"aimed":[74],"describe":[76],"clinical":[78,158,623],"characteristics,":[79,159,638],"treatment":[80,121,160,172,180,398,642],"patterns,":[81,161],"outcomes":[83,624],"of":[84,141,198,223,233,316,422,453,466,481,494,518,648,661],"patients":[85,114,225,287,423,454,482,519],"relative":[89],"broader":[92,659],"cohort.":[94,357,529,551,573,595,613,652],"Methods:":[95],"This":[96,614],"retrospective":[97],"cohort":[98,135,194,291,322,337,350,388,393,427,443,523,541,563,585],"US-based":[102],"Flatiron":[103],"Health":[104],"Research":[105],"Database":[106],"(data":[107],"cutoff:":[108],"May":[109],"31,":[110],"2024)":[111],"analyze":[113],"who":[117],"initiated":[118,455,460],"first-line":[119],"(1L)":[120],"on":[122],"or":[123,148,151,181,218],"after":[124],"January":[125],"1,":[126],"2014.":[127],"Patients":[128,303,318],"were":[129,184,202,292,323,508,607,644],"categorized":[130],"into":[131],"high":[133],"risk":[134],"if":[136],"their":[137],"had":[139,216,237,243,251,257,310,435],"\u22651":[140],"following:":[143],"documented":[144],"mutation,":[146,207,240],"blastoid":[147,217,252],"pleomorphic":[149,219,258],"Ki67":[152,606],"proliferation":[153,246],"index":[154,247],"\u226530%.":[155],"Baseline":[156],"demographics,":[157],"outcomes,":[163],"including":[164],"overall":[166,193,279,308,336,356,371,392,406,432,442,478,528,550,572,594,611,650],"survival":[167],"(rwOS),":[168],"time":[170,177],"discontinuation":[173],"(rwTTD),":[174],"next":[179],"death":[182],"(rwTTNTD),":[183],"summarized":[185],"descriptively":[186],"using":[187],"unadjusted":[188],"Kaplan-Meier":[189],"analyses.":[190],"Results:":[191],"The":[192],"included":[195],"1657":[196],"patients,":[197],"whom":[199,234],"204":[200],"(12.3%)":[201],"tested":[203,210],"622":[208],"(37.5%)":[209],"Ki67,":[212],"168":[214],"(10.1%)":[215],"morphology.":[220,259],"A":[221],"total":[222],"465":[224],"(28.1%)":[226],"met":[227],"criteria":[228],"cohort,":[232,268,280,433,451,479],"53":[235],"(11.4%)":[236],"344":[241],"(74.0%)":[242],"Ki-67":[245],"\u226530%,":[248],"113":[249],"(24.3%)":[250],"55":[255],"(11.8%)":[256],"Median":[260,341,396,530,552,574],"age":[261],"was":[262,343,359,381,400,418,532,554,576],"68.0":[263],"years":[264,276],"in":[265,277,288,304,319,365,385,424,430,438,469,474,497,502,520,526,538,548,560,570,582,592,609,634,664],"293":[270],"aged":[271,283],"\u226565":[272,284],"years,":[273],"69.0":[275],"1,065":[282],"years.":[285],"Most":[286],"male":[293],"(73.8%)":[294],"White":[296],"(76.3%)":[297],"stage":[299],"IV":[300],"(54.2%).":[302],"cohorts":[309,407],"same":[312],"median":[313,464,492],"MIPI":[314],"6.1.":[317],"more":[324,383],"frequently":[325],"managed":[326],"at":[327,331],"academic":[328],"centers":[329,333],"than":[330],"community":[332],"vs":[334,339,391,409,441,445],"(24.5%":[338],"19.6%).":[340],"follow-up":[342],"21.4":[344],"months":[345],"(mos)":[346],"28.5":[352],"mos":[353,468,473,496,501,534,544,556,566,578,588],"Bendamustine-rituximab":[358],"most":[361,510],"common":[362],"1L":[363,397,412,641],"regimen":[364],"(47.7%;":[368],"n=222)":[369],"(53.5%;":[372],"n=886)":[373],"cohorts.":[374],"Bruton":[375],"tyrosine":[376],"kinase":[377],"inhibitor":[378],"(BTKi)-based":[379],"chemoimmunotherapy":[380],"often":[384],"(7.1%;":[389],"n=33)":[390],"(4.8%;":[394],"n=79).":[395],"duration":[399,437],"similar":[401,645],"between":[402],"(4.6":[408],"4.9":[410,555],"mos).":[411,447],"maintenance":[413],"therapy":[414,457,485,627],"(rituximab":[415],"monotherapy":[416],"only)":[417],"received":[419,483,488,515],"by":[420,516],"26.5%":[421],"28.5%":[429],"shorter":[436],"(14.3":[444],"19.6":[446],"51.2%":[452],"2L":[456,470,484,498,513],"28.0%":[459],"3L":[461,489],"therapy,":[462,490],"durations":[465,493],"3.8":[467],"2.5":[472],"3L.":[475,503],"46.8%":[480],"24.1%":[487],"4.6":[495],"2.8":[500],"2L,":[505],"BTKi-containing":[506],"regimens":[507],"regimen,":[514],"58.8%":[517],"49.3%":[525],"rwTTNTD":[531],"12.1":[533],"(95%":[535,545,557,567,579,589],"CI,":[536,546,558,568,580,590],"10.3-15.9)":[537],"23.0":[543],"19.8-27.1)":[547],"rwTTD":[553],"4.7-6.1)":[559],"6.7":[565],"5.9-7.8)":[569],"rwOS":[575],"49.7":[577],"36.7-65.7)":[581],"73.2":[587],"64.3-79.6)":[591],"Conclusion:":[596],"study,":[600],"testing":[601,663],"rates":[602],"low":[608],"described":[616],"subgroup":[620],"showing":[621],"poor":[622,632],"across":[625],"multiple":[626],"lines.":[628],"Despite":[629],"established":[631],"prognosis":[633],"MCL,":[636],"baseline":[637],"MIPI,":[639],"patterns":[643],"those":[647],"These":[653],"findings":[654],"highlight":[655],"need":[657],"adoption":[660],"biomarker":[662],"routine":[665],"care":[666],"better":[668,679],"identify":[669],"manage":[671],"MCL.":[673],"Further":[674],"research":[675],"needed":[677],"integrate":[680],"biomarker-informed":[681],"strategies":[682],"improve":[684],"patient":[685]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2025-12-05T00:00:00"}